BioCentury
ARTICLE | Company News

Rexahn, The Ohio State University deal

October 21, 2013 7:00 AM UTC

Rexahn received an exclusive license to lipid-coated albumin nanoparticle (LCAN) drug delivery technology from the university's Ohio State Innovation Foundation. According to Rexahn, preclinical studi...